Log in to save to my catalogue

A Single Cell Atlas of Lung Development

A Single Cell Atlas of Lung Development

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2505703515

A Single Cell Atlas of Lung Development

About this item

Full title

A Single Cell Atlas of Lung Development

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

Journal title

bioRxiv, 2021-01

Language

English

Formats

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

Summary Lung organogenesis requires precisely timed shifts in the spatial organization and function of parenchymal cells, especially during the later stages of lung development. To investigate the mechanisms governing lung parenchymal dynamics during development, we performed a single cell RNA sequencing (scRNA-seq) time-series yielding 92,238 epithelial, endothelial, and mesenchymal cells across 8 time points from embryonic day 12 (E12) to postnatal day 14 (P14) in mice. We combined new computational analyses with RNA in situ hybridization to explore transcriptional velocity, fate likelihood prediction, and spatiotemporal localization of cell populations during the transition between the saccular and alveolar stages. We interrogated this atlas to illustrate the complexity of type 1 pneumocyte function during the saccular and alveolar stages, and we demonstrate an integrated view of the cellular dynamics during lung development. Competing Interest Statement JAK has received advisory board fees from Boehringer Ingelheim, Inc and Janssen Therapeutics, grants from Boehringer Ingelheim, Inc, and has research contracts with Genentech. TSB has received advisory board fees from Boehringer Ingelheim, Inc, Orinove, GRI Bio, Morphic, and Novelstar, and has research contracts with Genentech and Celgene. Footnotes * Competing Interests JAK has received advisory board fees from Boehringer Ingelheim, Inc and Janssen Therapeutics, grants from Boehringer Ingelheim, Inc, and has research contracts with Genentech. TSB has received advisory board fees from Boehringer Ingelheim, Inc, Orinove, GRI Bio, Morphic, and Novelstar, and has research contracts with Genentech and Celgene. * Figures and supplemental files updated. * https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE160876 * https://github.com/SucreLab/LungDevelopment...

Alternative Titles

Full title

A Single Cell Atlas of Lung Development

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2505703515

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2505703515

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/2021.01.21.427641